483
Amgen Manufacturing LtdFDA 483 - Amgen Manufacturing Ltd - May 10, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Amgen Manufacturing Limited in Juncos, PR, was cited for deficiencies in its quality system during an inspection of its human drug manufacturing facility. The firm failed to adequately investigate product complaints for trends and causes, particularly for products like Enbrel and Repatha. Additionally, the annual product review for Enbrel did not include a required evaluation of complaints, despite distributed batches being within shelf life.
Open in Dashboard
ID · 90311ed7-7358-4c93-a318-71514a142128